Psorigon Victim Searching for Alternatives
from Ron S.

Hi Ed.  Psorigon came along, I purchased a small amount and tried it with miraculous results.  Even my dermatologist was amazed stating that it must be the Urea in it that was making it so effective.

Then I received a letter from Psorigon stating that it was to be taken off the market while they attempted to get a license to sell it as a drug in the UK.  British regulations were much tighter than those in the States, they implied, so it would probably take a couple of years.  But in the meantime I should try PS-98, a temporary replacement.

I tried the PS-98 and it was useless. I became seriously depressed after a solution was taken away from me. On a positive note, I believe there are some very successful tests being performed with excellent results in the UK and at Musgrave Hospital in Northern Ireland using a genetically modified blood serum as a treatment for Psoriatic Arthritis, but which has actually been seen to drastically reduce the Psoriasis itself!

If you know anything of either of these treatments please let me know because I go a little bit more insane with each tube of Diprosalic or Dovanex I open! -Ron S. - Desperate!

*****

Ed’s Response:  We hear your pain, Ron!  As you probably know from browsing here (Archives), the Psorigon War has been pretty extensively covered (thank you Cherry S.).  Add your name to the list of thousands who felt abandoned when Psorigon disappeared and unrequited by PS-98.  It was the UK’s version of the US Skin-Cap debacle.  Same sin — giving us too much of a good thing clandestinely.

I don’t know anything specific about the tests you describe, but we just achieved approval of Enbrel in the U.S., which is a “biologic” drug for arthritis now formally for psoriatic arthritis, too, and known through the trials to improve skin P, as well.  Sounds suspiciously similar — but I won’t wager a guess. 

Fact is there are over 30 new drugs in the US drug-approval pipeline and several are this new type — biologics — derived from living tissue (blood serum?) rather than plain chemistry.  Some of these drugs target specific kinds of T-cells that work as part of the immune system; T-cells believed to be specific contributors to psoriasis.  The new drugs are supposed to block these T-cells from doing their P-triggering-thing.  By so narrowly defining the action of a specific type of cell, less risk to the immune system at large is the anticipated benefit. 

I’m on the waiting list for Enbrel and “excited in general” about all the other breaking developments.  Chances are, Ron, you’ll have your own alternatives to “Diprosalic or Dovanex” long before they have to lock you up in the insane asylum.

Good luck!  -Ed

This Month's Mail | Archives